A carregar...

Immunotherapy in Urothelial Cancer, Part 2: Adjuvant, Neoadjuvant, and Adjunctive Treatment

Urothelial cancer, which is predominantly seen in men, is common throughout the world. Most disease presents as non–muscle invasive bladder cancer (NMIBC), with cancer recurring or progressing to muscle invasive disease in more than 50% of patients after initial therapy. NMIBC is an immune responsiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Adv Hematol Oncol
Main Authors: Yu, Steven S., Ballas, Leslie K., Skinner, Eila C., Dorff, Tanya B., Sadeghi, Sarmad, Quinn, David I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523177/
https://ncbi.nlm.nih.gov/pubmed/28749918
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!